Shares of drug firm AstraZeneca today fell by nearly 5 per cent after it reported a net loss of Rs 27.96 crore for the second quarter ended on September 2014.
AstraZeneca's stock plunged 4.46 per cent to settle at Rs 871.50 on the BSE. During the day, it lost 5.16 per cent to Rs 865.05.
At the NSE, the scrip slumped 4.68 per cent to end at Rs 870.60.
The company had a net loss of Rs 1.22 crore in the July-September quarter period of the last fiscal.
AstraZeneca's total income from operation during the quarter under review was at Rs 114.67 crore against Rs 115.66 crore in the second quarter of the last fiscal, the company had said in a filing to the BSE on Monday.
The company had said that the result was not comparable as AstraZeneca group companies had acquired the global diabetic business of Bristol Myers Squibb Company.
